StemCell Therapy

DUARTE, Calif.--(BUSINESS WIRE)--City of Hope, a world-renowned independent cancer and diabetes research and treatment center, today announced it has renamed its preeminent diabetes research center the Arthur Riggs Diabetes & Metabolism Research Institute, in honor of its longtime director and research pioneer. Riggs scientific achievements include developing the technology that led to the first synthetic human insulin a breakthrough that enabled mass production of insulin for people with diabetes. That discovery, which jumpstarted what is now a $500 billion global biotech industry, was followed by numerous firsts in the field of biomedical science. Today, synthetic insulin is used regularly by hundreds of millions of people.

Riggs, the Samuel Rahbar Chair in Diabetes & Drug Discovery, also developed recombinant DNA technology capable of producing humanized monoclonal antibodies that are the foundation of modern treatments for diabetes, cancer, autoimmune diseases, blindness and a host of other diseases. These therapies include trastuzumab (commercial name: Herceptin), rituximab (commercial name: Rituxan), pembrolizumab (commercial name: Keytruda) and many others that are some of the worlds most widely used cancer drugs.

Arthur Riggs is a true visionary and a scientific giant, said Robert Stone, president and CEO of City of Hope and the Helen and Morgan Chu Chief Executive Officer Distinguished Chair. Dr. Riggs has been essential to the institutes growth and accomplishments over five decades, as a researcher, discoverer, mentor and major donor. His contributions to biomedical research have transformed the lives of countless people living with serious diseases and his mark on City of Hope is an indelible one that will continue on in the institute that now bears his name.

At City of Hope, in addition to dedicating himself to scientific pursuits, Riggs has quietly contributed nearly all of the wealth from his discoveries to support leading-edge research toward the development of new treatments for the betterment of human health.

Over the past 30 years, Riggs has donated more than $310 million to City of Hope. His generosity culminated in a gift of $100 million in January 2021 that will help fund the continuation of research that has been his passion for more than half a century.

Until now, Riggs has insisted that his gifts remain anonymous so that any attention would not detract from his work. He elected to make his philanthropy public now in the hope of encouraging other donors to join City of Hopes fight against diabetes and cancer, especially at a time when new therapeutic discoveries are needed more than ever.

I came to City of Hope because the environment here offers exactly that hope for people with diabetes, cancer and many other serious diseases, Riggs said. I believe in the promise of our work at City of Hope so strongly that one day, probably sooner than most think, well create a world without diabetes. Yet, we will realize the full potential of this important work only through the generosity of many other donors who will choose to join us.

The Arthur Riggs Diabetes & Metabolism Research Institute is one of the worlds foremost scientific organizations dedicated to investigating the biology of diabetes and its treatment. It houses eight departments, including The Wanek Family Project for Type 1 Diabetes, and continues Riggs work under its newly appointed director, Debbie C. Thurmond, Ph.D., the Ruth B. & Robert K. Lanman Chair in Gene Regulation & Drug Discovery Research.

It has been a humbling honor to assume responsibility for this institute that Dr. Riggs so purposefully and painstakingly built, Thurmond said. Its entirely fitting that it should carry his name as we carry on the work he began for the benefit of people with diabetes. His philanthropy is an extension of the generosity of spirit he has shown to me and everyone else who has ever walked through these doors, and his impact will be with us for many years to come.

About City of HopeCity of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hopes translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hopes exceptional cancer expertise. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nations Best Hospitals in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.

See the original post here:
City of Hope Renames World-Class Research Center the Arthur Riggs Diabetes & Metabolism Research Institute - Business Wire

This entry was posted on February 14, 2021 at 7:23 pm and is filed under Blindness. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |